Experimental myasthenia gravis: a model of receptor disease.
D000818:Animals; D002038:Bungarotoxins / Q000494:pharmacology; D003176:Complement C3 / Q000032:analysis; D004195:Disease Models, Animal; D004557:Electric Organ / Q000294:innervation; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007074:Immunoglobulin G / Q000032:analysis; D008954:Models, Biological; D009045:Motor Endplate / Q000187:drug effects / Q000276:immunology; D009157:Myasthenia Gravis / Q000276:immunology*; D011817:Rabbits; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000276:immunology*; D013569:Synapses / Q000276:immunology; D009435:Synaptic Transmission / Q000187:drug effects; D014101:Torpedo
D002038:Bungarotoxins; D003176:Complement C3; D007074:Immunoglobulin G; D011950:Receptors, Cholinergic